Selected research
Industry Growth & Trends
Global Sirolimus Coated Stent Industry Growth and Trends Forecast to 2032
Market perspective
The global Sirolimus Coated Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Sirolimus Coated Stent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Sirolimus Coated Stent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sirolimus Coated Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sirolimus Coated Stent include MicroPort Scientific Corporation, Shanghai Bio-heart Biological Technology, Shandong Huaan Biotechnology, SINOMED, Lepu Medical Technology, Blue Sail Medical, Kinhely Bio-Tech, JW Medical Systems and USM Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Sirolimus Coated Stent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sirolimus Coated Stent market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sirolimus Coated Stent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sirolimus Coated Stent.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Sirolimus Coated Stent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sirolimus Coated Stent Market by Company
MicroPort Scientific Corporation
Shanghai Bio-heart Biological Technology
Shandong Huaan Biotechnology
SINOMED
Lepu Medical Technology
Blue Sail Medical
Kinhely Bio-Tech
JW Medical Systems
USM Healthcare
Terumo
P+F Products + Features GmbH
MicroPort
Concept Medical Inc
Cardionovum
Biotronik
B. Braun
Sirolimus Coated Stent Segment by Type
Stainless Steel Material
Cobalt Chromium Alloy Material
Others
Sirolimus Coated Stent Segment by Application
Hospital
Clinic
Others
Sirolimus Coated Stent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sirolimus Coated Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sirolimus Coated Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sirolimus Coated Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sirolimus Coated Stent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sirolimus Coated Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stainless Steel Material
- Cobalt Chromium Alloy Material
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- MicroPort Scientific Corporation
- Shanghai Bio-heart Biological Technology
- Shandong Huaan Biotechnology
- SINOMED
- Lepu Medical Technology
- Blue Sail Medical
- Kinhely Bio-Tech
- JW Medical Systems
- USM Healthcare
- Terumo
- P+F Products + Features GmbH
- MicroPort
- Concept Medical Inc
- Cardionovum
- Biotronik
- B. Braun
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Sirolimus Coated Stent Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Sirolimus Coated Stent Sales Estimates and Forecasts (2021-2032)
- 1.3 Sirolimus Coated Stent Market by Type
- 1.3.1 Stainless Steel Material
- 1.3.2 Cobalt Chromium Alloy Material
- 1.3.3 Others
- 1.4 Global Sirolimus Coated Stent Market Size by Type
- 1.4.1 Global Sirolimus Coated Stent Market Size Overview by Type (2021-2032)
- 1.4.2 Global Sirolimus Coated Stent Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Sirolimus Coated Stent Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Sirolimus Coated Stent Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Sirolimus Coated Stent Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Sirolimus Coated Stent Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Sirolimus Coated Stent Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Sirolimus Coated Stent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Sirolimus Coated Stent Industry Trends
- 2.2 Sirolimus Coated Stent Industry Drivers
- 2.3 Sirolimus Coated Stent Industry Opportunities and Challenges
- 2.4 Sirolimus Coated Stent Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Sirolimus Coated Stent Revenue (2021-2026)
- 3.2 Global Top Players by Sirolimus Coated Stent Sales (2021-2026)
- 3.3 Global Top Players by Sirolimus Coated Stent Price (2021-2026)
- 3.4 Global Sirolimus Coated Stent Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sirolimus Coated Stent Major Company Production Sites & Headquarters
- 3.6 Global Sirolimus Coated Stent Company, Product Type & Application
- 3.7 Global Sirolimus Coated Stent Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sirolimus Coated Stent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sirolimus Coated Stent Players Market Share by Revenue in 2025
- 3.8.3 2025 Sirolimus Coated Stent Tier 1, Tier 2, and Tier 3
4 Sirolimus Coated Stent Regional Status and Outlook
- 4.1 Global Sirolimus Coated Stent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Sirolimus Coated Stent Historic Market Size by Region
- 4.2.1 Global Sirolimus Coated Stent Sales in Volume by Region (2021-2026)
- 4.2.2 Global Sirolimus Coated Stent Sales in Value by Region (2021-2026)
- 4.2.3 Global Sirolimus Coated Stent Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Sirolimus Coated Stent Forecasted Market Size by Region
- 4.3.1 Global Sirolimus Coated Stent Sales in Volume by Region (2027-2032)
- 4.3.2 Global Sirolimus Coated Stent Sales in Value by Region (2027-2032)
- 4.3.3 Global Sirolimus Coated Stent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sirolimus Coated Stent by Application
- 5.1 Sirolimus Coated Stent Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Sirolimus Coated Stent Market Size by Application
- 5.2.1 Global Sirolimus Coated Stent Market Size Overview by Application (2021-2032)
- 5.2.2 Global Sirolimus Coated Stent Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Sirolimus Coated Stent Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Sirolimus Coated Stent Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Sirolimus Coated Stent Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Sirolimus Coated Stent Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Sirolimus Coated Stent Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Sirolimus Coated Stent Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 MicroPort Scientific Corporation
- 6.1.1 MicroPort Scientific Corporation Company Information
- 6.1.2 MicroPort Scientific Corporation Business Overview
- 6.1.3 MicroPort Scientific Corporation Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 MicroPort Scientific Corporation Sirolimus Coated Stent Product Portfolio
- 6.1.5 MicroPort Scientific Corporation Recent Developments
- 6.2 Shanghai Bio-heart Biological Technology
- 6.2.1 Shanghai Bio-heart Biological Technology Company Information
- 6.2.2 Shanghai Bio-heart Biological Technology Business Overview
- 6.2.3 Shanghai Bio-heart Biological Technology Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanghai Bio-heart Biological Technology Sirolimus Coated Stent Product Portfolio
- 6.2.5 Shanghai Bio-heart Biological Technology Recent Developments
- 6.3 Shandong Huaan Biotechnology
- 6.3.1 Shandong Huaan Biotechnology Company Information
- 6.3.2 Shandong Huaan Biotechnology Business Overview
- 6.3.3 Shandong Huaan Biotechnology Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shandong Huaan Biotechnology Sirolimus Coated Stent Product Portfolio
- 6.3.5 Shandong Huaan Biotechnology Recent Developments
- 6.4 SINOMED
- 6.4.1 SINOMED Company Information
- 6.4.2 SINOMED Business Overview
- 6.4.3 SINOMED Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 SINOMED Sirolimus Coated Stent Product Portfolio
- 6.4.5 SINOMED Recent Developments
- 6.5 Lepu Medical Technology
- 6.5.1 Lepu Medical Technology Company Information
- 6.5.2 Lepu Medical Technology Business Overview
- 6.5.3 Lepu Medical Technology Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Lepu Medical Technology Sirolimus Coated Stent Product Portfolio
- 6.5.5 Lepu Medical Technology Recent Developments
- 6.6 Blue Sail Medical
- 6.6.1 Blue Sail Medical Company Information
- 6.6.2 Blue Sail Medical Business Overview
- 6.6.3 Blue Sail Medical Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Blue Sail Medical Sirolimus Coated Stent Product Portfolio
- 6.6.5 Blue Sail Medical Recent Developments
- 6.7 Kinhely Bio-Tech
- 6.7.1 Kinhely Bio-Tech Company Information
- 6.7.2 Kinhely Bio-Tech Business Overview
- 6.7.3 Kinhely Bio-Tech Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Kinhely Bio-Tech Sirolimus Coated Stent Product Portfolio
- 6.7.5 Kinhely Bio-Tech Recent Developments
- 6.8 JW Medical Systems
- 6.8.1 JW Medical Systems Company Information
- 6.8.2 JW Medical Systems Business Overview
- 6.8.3 JW Medical Systems Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 JW Medical Systems Sirolimus Coated Stent Product Portfolio
- 6.8.5 JW Medical Systems Recent Developments
- 6.9 USM Healthcare
- 6.9.1 USM Healthcare Company Information
- 6.9.2 USM Healthcare Business Overview
- 6.9.3 USM Healthcare Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 USM Healthcare Sirolimus Coated Stent Product Portfolio
- 6.9.5 USM Healthcare Recent Developments
- 6.10 Terumo
- 6.10.1 Terumo Company Information
- 6.10.2 Terumo Business Overview
- 6.10.3 Terumo Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Terumo Sirolimus Coated Stent Product Portfolio
- 6.10.5 Terumo Recent Developments
- 6.11 P+F Products + Features GmbH
- 6.11.1 P+F Products + Features GmbH Company Information
- 6.11.2 P+F Products + Features GmbH Business Overview
- 6.11.3 P+F Products + Features GmbH Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 P+F Products + Features GmbH Sirolimus Coated Stent Product Portfolio
- 6.11.5 P+F Products + Features GmbH Recent Developments
- 6.12 MicroPort
- 6.12.1 MicroPort Company Information
- 6.12.2 MicroPort Business Overview
- 6.12.3 MicroPort Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 MicroPort Sirolimus Coated Stent Product Portfolio
- 6.12.5 MicroPort Recent Developments
- 6.13 Concept Medical Inc
- 6.13.1 Concept Medical Inc Company Information
- 6.13.2 Concept Medical Inc Business Overview
- 6.13.3 Concept Medical Inc Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Concept Medical Inc Sirolimus Coated Stent Product Portfolio
- 6.13.5 Concept Medical Inc Recent Developments
- 6.14 Cardionovum
- 6.14.1 Cardionovum Company Information
- 6.14.2 Cardionovum Business Overview
- 6.14.3 Cardionovum Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Cardionovum Sirolimus Coated Stent Product Portfolio
- 6.14.5 Cardionovum Recent Developments
- 6.15 Biotronik
- 6.15.1 Biotronik Company Information
- 6.15.2 Biotronik Business Overview
- 6.15.3 Biotronik Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Biotronik Sirolimus Coated Stent Product Portfolio
- 6.15.5 Biotronik Recent Developments
- 6.16 B. Braun
- 6.16.1 B. Braun Company Information
- 6.16.2 B. Braun Business Overview
- 6.16.3 B. Braun Sirolimus Coated Stent Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 B. Braun Sirolimus Coated Stent Product Portfolio
- 6.16.5 B. Braun Recent Developments
7 North America by Country
- 7.1 North America Sirolimus Coated Stent Sales by Country
- 7.1.1 North America Sirolimus Coated Stent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Sirolimus Coated Stent Sales by Country (2021-2026)
- 7.1.3 North America Sirolimus Coated Stent Sales Forecast by Country (2027-2032)
- 7.2 North America Sirolimus Coated Stent Market Size by Country
- 7.2.1 North America Sirolimus Coated Stent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Sirolimus Coated Stent Market Size by Country (2021-2026)
- 7.2.3 North America Sirolimus Coated Stent Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Sirolimus Coated Stent Sales by Country
- 8.1.1 Europe Sirolimus Coated Stent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Sirolimus Coated Stent Sales by Country (2021-2026)
- 8.1.3 Europe Sirolimus Coated Stent Sales Forecast by Country (2027-2032)
- 8.2 Europe Sirolimus Coated Stent Market Size by Country
- 8.2.1 Europe Sirolimus Coated Stent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Sirolimus Coated Stent Market Size by Country (2021-2026)
- 8.2.3 Europe Sirolimus Coated Stent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Sirolimus Coated Stent Sales by Country
- 9.1.1 Asia-Pacific Sirolimus Coated Stent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Sirolimus Coated Stent Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Sirolimus Coated Stent Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Sirolimus Coated Stent Market Size by Country
- 9.2.1 Asia-Pacific Sirolimus Coated Stent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Sirolimus Coated Stent Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Sirolimus Coated Stent Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Sirolimus Coated Stent Sales by Country
- 10.1.1 South America Sirolimus Coated Stent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Sirolimus Coated Stent Sales by Country (2021-2026)
- 10.1.3 South America Sirolimus Coated Stent Sales Forecast by Country (2027-2032)
- 10.2 South America Sirolimus Coated Stent Market Size by Country
- 10.2.1 South America Sirolimus Coated Stent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Sirolimus Coated Stent Market Size by Country (2021-2026)
- 10.2.3 South America Sirolimus Coated Stent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Sirolimus Coated Stent Sales by Country
- 11.1.1 Middle East and Africa Sirolimus Coated Stent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Sirolimus Coated Stent Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Sirolimus Coated Stent Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Sirolimus Coated Stent Market Size by Country
- 11.2.1 Middle East and Africa Sirolimus Coated Stent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Sirolimus Coated Stent Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Sirolimus Coated Stent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Sirolimus Coated Stent Value Chain Analysis
- 12.1.1 Sirolimus Coated Stent Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Sirolimus Coated Stent Production Mode & Process
- 12.2 Sirolimus Coated Stent Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Sirolimus Coated Stent Distributors
- 12.2.3 Sirolimus Coated Stent Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst